Pharmaceuticals & Healthcare · Policy Lab
Antimicrobial Resistance
A public research route covering institutions, existing frameworks, possible interventions, and open policy questions.
How to interpret these labels
Urgency is a qualitative editorial assessment of time sensitivity and potential severity in the underlying working research. Addressability is a qualitative assessment of whether identifiable institutions and public interventions may materially affect the issue. The labels are research triage categories; they are not measured forecasts, comparative rankings, or recommendations. Recheck both classifications against current primary sources before use.
Possible public intervention
PASTEUR Act (pull incentives for novel antibiotics). Livestock sub-therapeutic use ban. Hospital antibiotic stewardship mandates. Resistance surveillance funding.
Institutions to examine
- Food and Drug Administration (FDA)
- Centers for Disease Control (CDC)
- World Health Organization (WHO)
- United States Department of Agriculture (USDA)
Institution abbreviations
- FDA
- U.S. Food and Drug Administration
- USDA
- U.S. Department of Agriculture
- CDC
- Centers for Disease Control and Prevention
- WHO
- World Health Organization
- EU
- European Union
- HELP
- U.S. Senate Committee on Health, Education, Labor, and Pensions
Existing frameworks and precedents
- National Action Plan for Combating Antibiotic-Resistant Bacteria
- WHO Global Action Plan on Antimicrobial Resistance
- EU ban on growth-promoting antibiotics (2006)
Open policy gap
Two new antibiotic classes in 40 years. Resistance evolving on 20-minute generation cycles. Livestock sub-therapeutic use drives resistance. PASTEUR Act stalled twice. The pharmaceutical pipeline cannot outrun bacterial evolution.
Legislative and policy forums
- HELP
- Agriculture
- Energy & Commerce
- ENVI
- AGRI
Continue the research
Use Reform Pathfinder to locate jurisdiction-specific institutions and possible action paths. Use the public glossary for terminology and the selected publications for public evidence and methods.
Research-use notice. This material is for research and educational use. Information may be incomplete or out of date. Verify primary sources, current law, institutional authority, source dates, and local applicability before acting. This site does not provide legal, financial, investment, regulatory, or implementation advice.